Asia-Pacific Therapeutic Nuclear Medicines Market Report 2017

Published Date : 2017-04-10

Published By : Qy Research Groups

Category : Pharma & Healthcare

No. of Pages : 101

In this report, the Asia-Pacific Therapeutic Nuclear Medicines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Therapeutic Nuclear Medicines for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Therapeutic Nuclear Medicines market competition by top manufacturers/players, with Therapeutic Nuclear Medicines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Therapeutic Nuclear Medicines for each application, includin
Hospitals
Ambulatory Surgical Centers
Other

Table of Contents

Asia-Pacific Therapeutic Nuclear Medicines Market Report 2017
1 Therapeutic Nuclear Medicines Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Classification of Therapeutic Nuclear Medicines by Product Category
1.2.1 Asia-Pacific Therapeutic Nuclear Medicines Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Therapeutic Nuclear Medicines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Beta Emitters Therapeutic Nuclear Medicines
1.2.4 Alpha Emitters Therapeutic Nuclear Medicines
1.2.5 Brachytherapy Therapeutic Nuclear Medicines
1.3 Asia-Pacific Therapeutic Nuclear Medicines Market by Application/End Users
1.3.1 Asia-Pacific Therapeutic Nuclear Medicines Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Other
1.4 Asia-Pacific Therapeutic Nuclear Medicines Market by Region
1.4.1 Asia-Pacific Therapeutic Nuclear Medicines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Therapeutic Nuclear Medicines (2012-2022)
1.5.1 Asia-Pacific Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Therapeutic Nuclear Medicines Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Therapeutic Nuclear Medicines Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Therapeutic Nuclear Medicines (Volume and Value) by Type
2.2.1 Asia-Pacific Therapeutic Nuclear Medicines Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Therapeutic Nuclear Medicines (Volume) by Application
2.4 Asia-Pacific Therapeutic Nuclear Medicines (Volume and Value) by Region
2.4.1 Asia-Pacific Therapeutic Nuclear Medicines Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Market Share by Region (2012-2017)

3 China Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
3.1 China Therapeutic Nuclear Medicines Sales and Value (2012-2017)
3.1.1 China Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017)
3.1.2 China Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
3.1.3 China Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
3.2 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
3.3 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

4 Japan Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
4.1 Japan Therapeutic Nuclear Medicines Sales and Value (2012-2017)
4.1.1 Japan Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
4.1.3 Japan Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
4.2 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
4.3 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

5 South Korea Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
5.1 South Korea Therapeutic Nuclear Medicines Sales and Value (2012-2017)
5.1.1 South Korea Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
5.2 South Korea Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
5.3 South Korea Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

6 Taiwan Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
6.1 Taiwan Therapeutic Nuclear Medicines Sales and Value (2012-2017)
6.1.1 Taiwan Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
6.2 Taiwan Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
6.3 Taiwan Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

7 India Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
7.1 India Therapeutic Nuclear Medicines Sales and Value (2012-2017)
7.1.1 India Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017)
7.1.2 India Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
7.1.3 India Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
7.2 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
7.3 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

8 Southeast Asia Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
8.1 Southeast Asia Therapeutic Nuclear Medicines Sales and Value (2012-2017)
8.1.1 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
8.2 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
8.3 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

9 Australia Therapeutic Nuclear Medicines (Volume, Value and Sales Price)
9.1 Australia Therapeutic Nuclear Medicines Sales and Value (2012-2017)
9.1.1 Australia Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
9.1.3 Australia Therapeutic Nuclear Medicines Sales Price Trend (2012-2017)
9.2 Australia Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
9.3 Australia Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

10 Asia-Pacific Therapeutic Nuclear Medicines Players/Suppliers Profiles and Sales Data
10.1 Cardinal Health
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Cardinal Health Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Mallkrodt Plc
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Mallkrodt Plc Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 GE Healthcare
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Lantheus Medical Imaging
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Bayer AG
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Bayer AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Bracco Imaging SpA
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Bracco Imaging SpA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Eczacibasi-Monrol Nuclear Products
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Nordion
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Nordion Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Advanced Accelerator Applications SA
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 IBA Molecular Imaging
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview

11 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
11.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Therapeutic Nuclear Medicines Market Forecast (2017-2022)
15.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Therapeutic Nuclear Medicines Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Therapeutic Nuclear Medicines Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Therapeutic Nuclear Medicines Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Therapeutic Nuclear Medicines Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Therapeutic Nuclear Medicines
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume Market Share by Type (Product Category) in 2016
Figure Beta Emitters Therapeutic Nuclear Medicines Product Picture
Figure Alpha Emitters Therapeutic Nuclear Medicines Product Picture
Figure Brachytherapy Therapeutic Nuclear Medicines Product Picture
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales (MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Therapeutic Nuclear Medicines by Application in 2016
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Other Examples
Figure Asia-Pacific Therapeutic Nuclear Medicines Market Size (Million USD) by Region (2012-2022)
Figure China Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Market Major Players Product Sales Volume (MT)(2012-2017)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales (MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
Figure Asia-Pacific Therapeutic Nuclear Medicines Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Therapeutic Nuclear Medicines Revenue Share by Players
Figure 2017 Asia-Pacific Therapeutic Nuclear Medicines Revenue Share by Players
Table Asia-Pacific Therapeutic Nuclear Medicines Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Share by Type (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Type (2012-2017)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type (2012-2017)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Share by Region (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Region (2012-2017)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Region in 2016
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Region (2012-2017)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share by Region in 2016
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017)
Figure China Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure China Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table China Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table China Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure China Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table China Therapeutic Nuclear Medicines Sales Volume (MT) by Applications (2012-2017)
Table China Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure China Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Figure Japan Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table Japan Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table Japan Therapeutic Nuclear Medicines Sales Volume (MT) by Applications (2012-2017)
Table Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Figure South Korea Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure South Korea Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table South Korea Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table South Korea Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure South Korea Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table South Korea Therapeutic Nuclear Medicines Sales Volume (MT) by Applications (2012-2017)
Table South Korea Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure South Korea Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Figure Taiwan Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Taiwan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table Taiwan Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table Taiwan Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table Taiwan Therapeutic Nuclear Medicines Sales Volume (MT) by Applications (2012-2017)
Table Taiwan Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Figure India Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table India Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table India Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure India Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table India Therapeutic Nuclear Medicines Sales Volume (MT) by Application (2012-2017)
Table India Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure India Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Figure Southeast Asia Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume (MT) by Applications (2012-2017)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Figure Australia Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Australia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Therapeutic Nuclear Medicines Sales Price (USD/MT) Trend (2012-2017)
Table Australia Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2017)
Table Australia Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2012-2017)
Figure Australia Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2016
Table Australia Therapeutic Nuclear Medicines Sales Volume (MT) by Applications (2012-2017)
Table Australia Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2012-2017)
Figure Australia Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2016
Table Cardinal Health Therapeutic Nuclear Medicines Basic Information List
Table Cardinal Health Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2012-2017)
Table Mallkrodt Plc Therapeutic Nuclear Medicines Basic Information List
Table Mallkrodt Plc Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2012-2017)
Table GE Healthcare Therapeutic Nuclear Medicines Basic Information List
Table GE Healthcare Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2012-2017)
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Basic Information List
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2012-2017)
Table Bayer AG Therapeutic Nuclear Medicines Basic Information List
Table Bayer AG Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2012-2017)
Table Bracco Imaging SpA Therapeutic Nuclear Medicines Basic Information List
Table Bracco Imaging SpA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2012-2017)
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Basic Information List
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2012-2017)
Table Nordion Therapeutic Nuclear Medicines Basic Information List
Table Nordion Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2012-2017)
Table Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Basic Information List
Table Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2012-2017)
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Basic Information List
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/MT) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2016
Table Major Buyers of Therapeutic Nuclear Medicines
Table Distributors/Traders List
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Price (USD/MT) and Trend Forecast (2017-2022)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share Forecast by Region in 2022
Figure China Therapeutic Nuclear Medicines Sales (MT) and Growth Rate Forecast (2017-2022)
Figure China Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Therapeutic Nuclear Medicines Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Therapeutic Nuclear Medicines Sales (MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Therapeutic Nuclear Medicines Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Therapeutic Nuclear Medicines Sales (MT) and Growth Rate Forecast (2017-2022)
Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Therapeutic Nuclear Medicines Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Australia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales (MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Therapeutic Nuclear Medicines Price (USD/MT) Forecast by Type (2017-2022)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales (MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-236-2744

sales@qyresearchgroups.com